News

An international group of haematology experts have written a report on the progress made in blood cancer treatment, and specifically the issue of toxicity from treatment. Dr Gita Thanarajasingam of the Mayo Clinic, Minnesota, USA...

Researchers have identified a possible increase in lymphoma risk for people taking Janus kinase inhibitors to treat myelofibrosis. The team, led by Dr Heinz Gisslinger, of the Medical University of Vienna in Austria, also believe...